| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8794717 | Ophthalmology Retina | 2018 | 8 Pages |
Abstract
Dyslipidemia is involved in the development of DR at an earlier stage, but the role of lipid-modulating agents in DR requires additional study.
Keywords
ICD-9-CMNHIRDETDRSNHIBRBNPDRDDDHDL-CPDRLDL-CACCORDDMELHIDWESDRapoapolipoproteinDiabetic macular edemaAction to Control Cardiovascular Risk in DiabetesNational Health Insuranceearly treatment diabetic retinopathy studyDefined daily doseDiabetes mellitusdiabetic retinopathynonproliferative diabetic retinopathyProliferative diabetic retinopathyAgeinternational classification of diseases, ninth revision, clinical modificationconfidence intervalhigh-density lipoprotein cholesterolhazard ratioLongitudinal Health Insurance DatabaseNational Health Insurance Research Databaseadvanced glycation end productLow-density lipoprotein cholesterol
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Chi-Juei MD, Yi-Ting MD, PhD, Chung-May MD, Chang-Hao MD, PhD, Cheng-Li MS, I-Jong MD, PhD,